Cannabis inhalers: study launched for cancer-related pain
Cannabis metered-dose inhalers to treat cancer patients, That's what they're going to test Israeli pharmaceutical companies Rafa and Panaxia during a clinical trial. This trial is part of the process to obtain marketing authorization for the device, which the two partner companies hope to bring to market this year. This would be a minor revolution in the world of medical cannabis, which is still struggling to determine the optimal routes of administration for the drug.
A New Administration Solution for Patients
Cannabis inhalers already exist, and some Israeli startups are currently working on the concept. However, this is the first time that this type of device has been the subject of a clinical trial aimed at approving this method of administration as part of a specific therapy—in this case, for neuropathic pain (related to cancer).
Alternatives to patches already exist, such as sprays or capsules, but the advantage of administration via an inhaler is the rapid onset of pain relief. The product is designed to provide immediate relief. As Dr. Itay Gur-Aryeh, director of the Pain Unit at Sheba Medical Center in Tel Hashomer, explains: «The inhalation route of administration is characterized by a faster response than oral or sublingual tablets.».
Another advantage of this inhaler is its precision. Preloaded with cannabis concentrates, the vaporizer inside the inhaler allows the patient to precisely measure the amount to be administered. The concentrate’s formulation ensures accuracy in terms of active ingredients, enabling the patient to precisely replicate the dose recommended by their doctor.
«By providing access to cannabis inhalers and with a specialist’s recommendation, we are striving to help more patients suffering from acute pain. »The inhaler will give patients who are unable or unwilling to smoke the right to receive effective and targeted treatment,” explains Dr. Dadi Segal, the CEO of Panaxia.
The clinical trial aims to obtain approval from the Ministry of Health to confirm the efficacy and safety of the metered-dose inhaler delivery method. The inhaler, designed by Panaxia, is scheduled to be marketed this year by Rafa Pharmaceuticals.
-
Business2 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France3 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec1 week ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in the U.S.3 weeks ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Studies on cannabis4 weeks ago
Cannabis Oil and Endometriosis: A Promising Study for Pain Relief
-
Cannabis in France3 weeks ago
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
-
Business3 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
CBD3 weeks ago
October 2026 CBD Highlights: 10 Strains and Hash to Discover from 5 French Producers


You must be logged in to post a comment Login